As the coronavirus pandemic continues to evolve, Cardiovascular Institute of the South (CIS) wants to assure our patients and community that it is important to continue cardiovascular care and not ignore any symptoms you may be having.

Your health and safety is important to us and our staff is trained to provide you with a safe experience. 

Here’s how we are protecting you.

  • CIS is following all CDC guidelines outlined for cleaning of patient exam rooms, waiting rooms, and diagnostic equipment.
  • CIS has a rigorous program in place to assure that our employees remain healthy and safe to care for patients at all times.
  • CIS has an established Covid-19 Task Force made up of Physicians, Nurse Practitioners, and Administrators that monitor local and national Covid-19 data on a daily basis.
  • Our facilities are safe and being monitored on an ongoing basis.
 
Before coming in for an appointment, please alert us if you: 
  • are currently experiencing respiratory or flu-like symptoms
  • have been in close contact with someone who has these symptoms
  • have had nausea, vomiting, or diarrhea in the last five days
  • have had a sudden loss of smell or taste
  • have a close family member that has been hospitalized in the last seven days

If you are experiencing any flu-like symptoms (fever, cough, shortness of breath) and have an appointment to see a CIS physician, please call the clinic in advance of your visit for additional instructions.

COVID-19 SAFETY FAQs

 

Learn more about the precautionary measures we are taking for your continued safety in this video message from Founder, President & Medical Director Dr. Craig Walker:

 

For additional resources, visit:

Louisiana Department of Health    |    Mississippi Department of Health    |    Center for Disease Control

 


For Patients Taking an ACE or ARB Medication:

On March 17, 2020, the American College of Cardiology, the Heart Failure Society of America and the American Heart Association issued a joint statement for patients diagnosed with high blood pressure (hypertension) or Congestive Heart Failure (CHF) amid the current pandemic of the COVID-19 coronavirus.

This statement addresses the concerns regarding current medications used to treat these disease processes.  These types of medications include ACE inhibitors (such as enalapril or isinopril) or ARBs (such as losartan or valsartan) or a combination of therapies such as (Entresto sacubitril/valsartan). These medications are for lowering blood pressure, while reducing the workload of the heart muscle. They also improve blood flow by relaxing blood vessels throughout the body.

There have been some concerns that these medications work on the site of action where the coronavirus enters the body.  In this joint statement, experts agree there is no clinical data showing that people who are taking ACEs or ARBs and have the COVID-19 infection have either a negative or  positive outcome.

The current recommendation is for patients who suffer from these conditions to continue to take their medications as instructed by their healthcare provider. Individuals with heart disease have a greater chance of serious illness and further complications if infected; therefore, it is recommended to remain on these medications as prescribed.

As always, please contact your healthcare provider prior to withholding any medications. In an effort to provide you with the highest quality of cardiovascular healthcare available, CIS is open 24/7 to answer any questions or provide additional information.

 

Precuation graphic-02